Jane L Sterner

Title: Jane L Sterner: Innovator in Biochemical Research

Introduction

Jane L Sterner is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biochemical research, particularly in the area of DNA sequencing and expression vectors. With a total of 2 patents, her work has advanced the understanding and application of genetic engineering.

Latest Patents

Jane's latest patents include innovative technologies such as DNA sequences encoding porcine pancreatic carboxypeptidase B and bacteriophage lambda pL promoters. The first patent focuses on DNA encoding porcine pro-carboxypeptidase B, vectors comprising the DNA, and host cells transformed with these vectors, which are useful for the production of porcine carboxypeptidase B. The second patent concerns novel DNA compounds that function as transcriptional activating sequences, providing recombinant DNA expression vectors that enable regulatable expression of operably linked genes and enhance the structural stability of the expression vector.

Career Highlights

Jane L Sterner is currently associated with Eli Lilly and Company, where she continues to push the boundaries of biochemical research. Her work has not only contributed to her personal achievements but has also played a vital role in the advancements made by her organization.

Collaborations

Throughout her career, Jane has collaborated with notable colleagues, including Charles L Hershberger and Jeffrey T Fayerman. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Jane L Sterner's contributions to the field of biochemical research exemplify the impact of innovative thinking in science. Her patents and collaborations highlight her commitment to advancing genetic engineering and its applications.